Poractant Alfa
ATC R07AA02 · 5 markets · 9 records
AU 3 records · 2 strengths
- 80 mg/mLliquidCUROSURF poractant alfa 120mg/1.5mL intratracheal suspension vial
Records without a stated strength · 1 Curosurf
GB 2 records · 2 strengths
- 240 mg/3 mLinjectionCurosurf 240mg/3ml endotracheopulmonary suspension vials
- 120 mg/1.5 mLinjectionCurosurf 240mg/3ml endotracheopulmonary suspension vials
HK 2 records · 1 strengths
Records without a stated strength · 1 CUROSURF SUSPENSION FOR INTRATRACHEAL 240MG/3ML、CUROSURF SUSPENSION FOR INTRATRACHEAL ADMINISTRATION 120MG/1.5ML
US 1 records · 1 strengths
- 80 mgliquidCurosurf
CA 1 records · 1 strengths
- 80 mgliquidCurosurf
| Strength / form / release | US | GB | CA | AU | HK |
|---|---|---|---|---|---|
| 80 mg liquid | Curosurf | Curosurf | |||
| 80 mg/mL liquid | CUROSURF poractant alfa 120mg/1.5mL intratracheal suspension vial | ||||
| 240 mg/3 mL injection | Curosurf 240mg/3ml endotracheopulmonary suspension vials | ||||
| 120 mg/1.5 mL injection | Curosurf 240mg/3ml endotracheopulmonary suspension vials | ||||
unknown | Curosurf | CUROSURF SUSPENSION FOR INTRATRACHEAL 240MG/3ML CUROSURF SUSPENSION FOR INTRATRACHEAL ADMINISTRATION 120MG/1.5ML |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.